Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

102 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Semaphorin3A: A potential therapeutic tool in immune-mediated diseases.
Vadasz Z, Toubi E. Vadasz Z, et al. Eur J Rheumatol. 2018 Mar;5(1):58-61. doi: 10.5152/eurjrheum.2017.17076. Epub 2017 Dec 7. Eur J Rheumatol. 2018. PMID: 29657877 Free PMC article. Review.
[IgM enriched immunoglobulins as a therapy for sepsis and autoimmune diseases].
Yehudai D, Vadasz Z. Yehudai D, et al. Among authors: vadasz z. Harefuah. 2012 Mar;151(3):171-4, 188. Harefuah. 2012. PMID: 22519268 Review. Hebrew.
Semaphorin 3A is a marker for disease activity and a potential immunoregulator in systemic lupus erythematosus.
Vadasz Z, Haj T, Halasz K, Rosner I, Slobodin G, Attias D, Kessel A, Kessler O, Neufeld G, Toubi E. Vadasz Z, et al. Arthritis Res Ther. 2012 Jun 14;14(3):R146. doi: 10.1186/ar3881. Arthritis Res Ther. 2012. PMID: 22697500 Free PMC article.
Semaphorins: their dual role in regulating immune-mediated diseases.
Vadasz Z, Toubi E. Vadasz Z, et al. Clin Rev Allergy Immunol. 2014 Aug;47(1):17-25. doi: 10.1007/s12016-013-8360-4. Clin Rev Allergy Immunol. 2014. PMID: 23397481 Review.
Age-related autoimmunity.
Vadasz Z, Haj T, Kessel A, Toubi E. Vadasz Z, et al. BMC Med. 2013 Apr 4;11:94. doi: 10.1186/1741-7015-11-94. BMC Med. 2013. PMID: 23556986 Free PMC article.
Autoimmunity and novel therapies in immune-mediated thrombocytopenia.
Yehudai D, Toubi E, Shoenfeld Y, Vadasz Z. Yehudai D, et al. Among authors: vadasz z. Semin Hematol. 2013 Jan;50 Suppl 1:S100-8. doi: 10.1053/j.seminhematol.2013.03.015. Semin Hematol. 2013. PMID: 23664506 Review.
B-regulatory cells in autoimmunity and immune mediated inflammation.
Vadasz Z, Haj T, Kessel A, Toubi E. Vadasz Z, et al. FEBS Lett. 2013 Jun 27;587(13):2074-8. doi: 10.1016/j.febslet.2013.05.023. Epub 2013 May 22. FEBS Lett. 2013. PMID: 23707422 Review.
Brief report: lysyl oxidase is a potential biomarker of fibrosis in systemic sclerosis.
Rimar D, Rosner I, Nov Y, Slobodin G, Rozenbaum M, Halasz K, Haj T, Jiries N, Kaly L, Boulman N, Daood R, Vadasz Z. Rimar D, et al. Among authors: vadasz z. Arthritis Rheumatol. 2014 Mar;66(3):726-30. doi: 10.1002/art.38277. Arthritis Rheumatol. 2014. PMID: 24574233
The role of B regulatory cells and Semaphorin3A in atopic diseases.
Vadasz Z, Haj T, Toubi E. Vadasz Z, et al. Int Arch Allergy Immunol. 2014;163(4):245-51. doi: 10.1159/000360477. Epub 2014 Apr 2. Int Arch Allergy Immunol. 2014. PMID: 24713604 Review.
Semaphorin 3A: an immunoregulator in systemic sclerosis.
Rimar D, Nov Y, Rosner I, Slobodin G, Rozenbaum M, Halasz K, Haj T, Jiries N, Kaly L, Boulman N, Vadasz Z. Rimar D, et al. Among authors: vadasz z. Rheumatol Int. 2015 Oct;35(10):1625-30. doi: 10.1007/s00296-015-3269-2. Epub 2015 Apr 21. Rheumatol Int. 2015. PMID: 25895648
102 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback